Melinta Therapeutics Inc (MLNTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,754 | -33,399 | -17,021 | -45,035 | -28,206 |
| Depreciation Amortization | 619 | 433 | 232 | 690 | 454 |
| Accounts receivable | -1,962 | 291 | -1,519 | -1,626 | -975 |
| Accounts payable and accrued liabilities | 4,488 | 3,129 | 2,513 | 4,102 | 1,717 |
| Other Working Capital | 6,078 | 641 | -939 | 8,474 | 6,537 |
| Other Operating Activity | -374 | -1,932 | -162 | 953 | 1,856 |
| Operating Cash Flow | $-35,906 | $-30,838 | $-16,896 | $-32,441 | $-18,616 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -37 | -37 | -21 | -134 | -51 |
| Investing Cash Flow | $-37 | $-37 | $-21 | $-134 | $-51 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,000 | 3,000 | N/A | 5,238 | 5,238 |
| Debt Repayment | N/A | N/A | N/A | -238 | -238 |
| Common Stock Issued | 10,682 | 49 | 2 | 54,470 | 54,462 |
| Other Financing Activity | -70 | -35 | -34 | -501 | -501 |
| Financing Cash Flow | $13,612 | $3,014 | $-31 | $58,969 | $58,961 |
| Beginning Cash Position | 96,503 | 96,503 | 96,503 | 70,109 | 70,109 |
| End Cash Position | 74,173 | 68,642 | 79,555 | 96,503 | 110,403 |
| Net Cash Flow | $-22,330 | $-27,861 | $-16,948 | $26,394 | $40,295 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,906 | -30,838 | -16,896 | -32,441 | -18,616 |
| Capital Expenditure | -37 | -37 | -21 | -134 | -51 |
| Free Cash Flow | -35,943 | -30,874 | -16,917 | -32,575 | -18,666 |